logo

For the Inventor, By the Inventor

Sartrouville, France

Ibtissam Loussert-Ajaka

This inventor holds 6 USPTO granted patents. Top assignees: National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris, Institut Pasteur. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ibtissam Loussert-Ajaka. Retrieved from https://idiyas.com/inventor/ibtissam-loussert-ajaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 66.7

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:

goldMedal5 out of 1,853 
 
National Institute of Health and Medical Research
 patents
silverMedal3 out of 331 
 
Assistance Publique-Hopitaux De Paris
 patents
bronzeMedal2 out of 898 
 
Institut Pasteur
 patents
4. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2012

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8227185 - Non-M, non-O HIV-1 strains, fragments and uses (2012-07-24),
2. 7534877 - Non-M, non-O HIV-1 strains, fragments and uses (2009-05-19),
3. 7030234 - Non-M, non-O HIV-1 strains, fragments and uses (2006-04-18),
4. 6509018 - Non-M non-O HIV strains, fragments and uses (2003-01-21),
5. 6270975 - Group O HIV-1, fragments of such viruses, and uses thereof (2001-08-07),
6. 6030769 - Group O HIV-1, fragments of such viruses, and uses thereof (2000-02-29),

Title: Ibtissam Loussert-Ajaka: Innovator in HIV Research

Introduction

Ibtissam Loussert-Ajaka is a prominent inventor based in Sartrouville, France. She has made significant contributions to the field of HIV research, particularly focusing on non-M, non-O HIV-1 strains. With a total of 6 patents to her name, her work has been instrumental in advancing diagnostic and therapeutic approaches to HIV.

Latest Patents

Her latest patents include innovations related to non-M, non-O HIV-1 strains and their fragments. One notable patent involves a retroviral strain designated YBF30, which is utilized as a diagnostic reagent and an immunogenic agent. Additionally, she has developed another strain, YBE30, which also serves similar purposes in diagnostics and immunogenic applications. These HIV-1 viruses exhibit unique characteristics that differentiate them from both the M and O groups.

Career Highlights

Throughout her career, Ibtissam has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. Her research has not only contributed to scientific knowledge but has also paved the way for potential advancements in HIV treatment and prevention.

Collaborations

Ibtissam has collaborated with notable colleagues in her field, including Sentob Saragosti and Philippe Mauclere. These partnerships have enhanced her research efforts and broadened the impact of her work.

Conclusion

Ibtissam Loussert-Ajaka's innovative contributions to HIV research highlight her role as a leading inventor in the field. Her patents and collaborations reflect her commitment to advancing medical science and improving health outcomes for individuals affected by HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…